ArticleOncoimmunology

RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer.

Elizabeth Ahern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.